Free medication will soon be provided to low-income cancer patients in the UAE.
It comes following a new agreement between the Ministry of Health and Prevention (MoHAP) and pharmaceutical company, AstraZeneca.
The initiative will benefit those battling bladder and lung cancer as well as patients with lymphoma and acute asthma.
Commenting on the agreement, Leon Wang, Executive VP at International AstraZeneca said: "This initiative, which includes new and innovative treatment for some types of cancer and respiratory diseases, would help patients, who are under limited medical insurance."
Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department said that the initiative would help enhance community responsibility values for companies.

UAE confirms first day of Ramadan
Dubai adjusts paid parking, Salik hours for Ramadan
Dubai expands road network with new Al Rowaiyah corridor
UAE extends Emirates Mars Mission until 2028
UAE joins 7 nations in condemning Israel's West Bank land registration plan
Dubai Holding, Nord Anglia Education partner to develop new premium schools
UAE President posts special message on Lunar New Year
New UAE, Bahrain fast-track travel system takes off
Dubai's Al Jalila Foundation unveils cancer support fund
Dubai Police crowned champions of UAE Rescue Challenge
UAE discusses strengthening partnership with NATO
Dubai Police urge vigilance against online begging
H.H. Sheikh Hamdan pays tribute to UAE's royal photographer
Sharjah approves over AED76 million in debt settlement for citizens
H.H. Sheikh Hamdan awards Arab Hope Makers
UAE looks into framework to regulate children's social media use
UAE Ramadan moon-sighting committee to meet on Tuesday
RTA opens second bridge at Al Qudra intersection
Abu Dhabi identifies over 40 modern heritage sites
Distribution of aid from UAE's Saqr Humanitarian Ship begins in Gaza
